Governor Polis and CDHS Launch Child Abuse Prevention Month, Highlight Resilience of Colorado Parents
News provided by
Share this article
Share this article
DENVER, April 1, 2021 /PRNewswire/ Today, Governor Jared Polis and Michelle Barnes, executive director of the Colorado Department of Human Services (CDHS), will join Colorado families, community partners, county leaders and child advocates for a virtual launch of Child Abuse Prevention Month. The online event can be viewed at facebook.com/CO4Kids and will feature four Colorado families sharing stories of parental resilience while parenting in the pandemic. COVID-19 has added stressors for parents and caregivers, requiring them to adjust to new norms while staying strong in the face of stress. Families are building and maintaining positive relationships with people they can call on for help and need access to the resources they need in order to thrive, said Barnes.
The market for surgical sutures is witnessing steady growth primarily due to the increasing number of surgical procedures performed globally. The favorable reimbursement scenario for a number of surgical procedures and the launch of advanced sutures are further contributing to the growth of this market. However, the presence of alternative wound care management products and the growing preference for minimally invasive surgeries are some of the factors expected to limit the growth of this market to a certain extent.
The Suture Threads segment accounted for the largest market share in 2020.
Based on product, the surgical sutures market has been segmented into suture threads and automated suturing devices. In 2020, the suture threads segment accounted for the largest market share of 82.6%. The large share of this segment can be attributed to the greater preference for suture threads for wound closure and their lower cost as compared to automated suturing devices.
SVB Leerink Continues Rapid Expansion with New Senior Managing Director in Leveraged Finance
News provided by
Share this article
Share this article
BOSTON, April 1, 2021 /PRNewswire/ SVB Leerink, a leading investment bank specializing in healthcare and life sciences, today announced Thad Davis has joined the firm as a Senior Managing Director.
Mr. Davis will be part of the team leading SVB Leerink s Leveraged Finance franchise, while contributing expertise that deepens the firm s strategic, M&A, and equity franchises. He joins recent hires Barry Blake, Global Co-Head of Investment Banking, and Robert Minear, Senior Managing Director, Financial Sponsors. SVB Leerink is excited to welcome Thad. His experience encompasses all healthcare sub-sectors including pharmaceuticals, life sciences, services, devices, technology and managed care, said Barry Blake, Global Co-Head of Investment Banking. Thad will provide immediate value to the team and will bring many significant clie
Share this article
Share this article
HAMILTON, ON and BOSTON, April 1, 2021 /PRNewswire/ Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines today announced the appointment of Donald A. Bergstrom, M.D., Ph.D., as a member of the Company s Board of Directors. Dr. Bergstrom, who currently serves as executive vice president, head of research and development at Relay Therapeutics, Inc., a clinical stage precision medicines company, brings to the board more than 15 years of experience in the biopharmaceutical industry. Don s depth of precision oncology and industry experience will be invaluable to us as we continue to progress our Targeted Alpha Therapies (TAT) platform and grow our pipeline of clinical candidates, said Fusion Chief Executive Officer John Valliant, Ph.D. Additionally, his leadership and understanding of the oncology landscape will provide Fusion with
Share this article
Share this article
ResearchAndMarkets.com s offering.
Global Medical Polymers Market to Reach $26.8 Billion by 2027
Amid the COVID-19 crisis, the global market for Medical Polymers estimated at US$ 16.5 Billion in the year 2020, is projected to reach a revised size of US$ 26.8 Billion by 2027, growing at a CAGR of 7.1% over the analysis period 2020-2027.
Resins & Fibers, one of the segments analyzed in the report, is projected to record a 7.1% CAGR and reach US$ 22.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Elastomers segment is readjusted to a revised 7.7% CAGR for the next 7-year period.